Vancomycin powder for Osteoarthritis

Phase 1
Led By Ran Schwarzkopf, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up90 days
Awards & highlights
No Placebo-Only Group
Approved for 5 Other Conditions
All Individual Drugs Already Approved

Study Summary

This trial will compare different ways to prevent joint infections after surgery.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of periprosthetic infection (PJI) after elective total joint arthroplasty.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Povidone iodine and vancomycin powderExperimental Treatment2 Interventions
Group II: Povidone iodine aloneExperimental Treatment1 Intervention
Group III: ConventionalActive Control1 Intervention
neither povidone iodine, vancomycin powder, nor polymyxin/bacitracin irrigation
Group IV: Vancomycin powder aloneActive Control1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
FDA approved

Find a site

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,326 Previous Clinical Trials
738,585 Total Patients Enrolled
17 Trials studying Osteoarthritis
1,979 Patients Enrolled for Osteoarthritis
Ran Schwarzkopf, MDPrincipal Investigator
NYU Langone
4 Previous Clinical Trials
760 Total Patients Enrolled
1 Trials studying Osteoarthritis
230 Patients Enrolled for Osteoarthritis

Media Library

Conventional Clinical Trial Eligibility Overview. Trial Name: NCT04075526 — Phase 1
Osteoarthritis Research Study Groups: Conventional, Vancomycin powder alone, Povidone iodine and vancomycin powder, Povidone iodine alone
Osteoarthritis Clinical Trial 2023: Conventional Highlights & Side Effects. Trial Name: NCT04075526 — Phase 1
Conventional 2023 Treatment Timeline for Medical Study. Trial Name: NCT04075526 — Phase 1
Osteoarthritis Patient Testimony for trial: Trial Name: NCT04075526 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can more people still join this research project?

"The trial is currently still recruiting patients, according to the information on This particular study was originally posted on October 1st, 2019 and updated as recently as February 25th, 2022."

Answered by AI

Does this research opportunity have an age limit?

"As long as they are between 18-100 years old, patients of any age can participate in this trial."

Answered by AI

What are some common off-label uses for Vancomycin powder?

"Vancomycin powder is the standard of care for preparting the periocular region before therapy. Additionally, Vancomycin powder has been shown to be useful in treating other conditions such as irrigation and cdad."

Answered by AI

Has the Vancomycin powder gone through testing by the FDA?

"Since this is a Phase 1 trial, there is only limited data to support the Vancomycin powder's safety."

Answered by AI

Are there any restrictions for who is able to participate in this research project?

"This large-scale clinical trial aims to enroll 10,000 patients aged 18 and 100 who are suffering from arthrosis. Eligible applicants will meet the following high-risk criteria for developing PJI: BMI >35, active smoker, ASA ≥ 3, immunosuppressed (i.e. being treated with chemotherapy, diagnosis of HIV, diagnosis of HCV, being treated with chronic steroids, patients with inflammatory arthropathies), diagnosis with diabetes mellitus, established colonization with S. aureus, or any patient undergoing revision TJA. Additionally, eligible candidates cannot have active infection on the operative leg or joint"

Answered by AI

How many different medical clinics are running this study today?

"There are currently 14 enrolling patients for this trial at locations such as Centura Health in Denver, Boston Medical Center in Chicago and Rush University Medical Center in Sparta. There are also other sites located throughout the country."

Answered by AI

How many individuals are included in this experimental research?

"In order to obtain accurate results, this study requires the participation of 10,000 individuals that meet the pre-specified requirements. Centura Health in Denver and Boston Medical Center in Chicago are two of the many hospitals where patients can take part in this trial."

Answered by AI

Does Vancomycin powder have a long history of being studied in humans?

"The first clinical trial studying vancomycin powder was conducted in 2010 at Sacramento Pediatric Gastroenterology. As of now, there have been a total 234 completed trials and 71 active ones. A high concentration of these active studies are based in Denver, Colorado."

Answered by AI

Who else is applying?

What state do they live in?
Rhode Island
New York
What site did they apply to?
New England Baptist Hospital
Mount Sinai Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Worry about infection staff ect and today don’t wash clean disinfectant the area of skin before and after surgery.
~2222 spots leftby Jan 2025